MELISSA WALLACE: Open Payments
NPI 1497027247 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 15 payments from 10 companies in 2025. Trend: 2023 $733 · 2024 $614 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Evofem Biosciences, Inc. | 3 | $50 |
| Sage Therapeutics, LLC | 3 | $45 |
| Astellas Pharma US Inc | 2 | $43 |
| Organon LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $19 |
| MILLICENT US INC | 1 | $16 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: Phexxi, ZURZUVAE, Veozah, NEXPLANON, Cologuard Collection Kit, ABRYSVO, SLYND, FEMLYV.
Industry payments across MO — which companies pay providers there.
